CompletedNot Applicable

Comparison of the Efficacy of Platelet-rich Fibrin and Connective Tissue Graft in Interdental Papilla Reconstruction

Turkey (Türkiye)55 participantsStarted 2018-09-05

Plain-language summary

Aim: To evaluate the efficacy of platelet-rich fibrin (PRF) or connective tissue graft (CTG) in papilla reconstruction (PR) with semilunar incision (SI) technique. Materials and Methods: A total of 55 sites (27 CTG and 28 PRF) from 20 patients who underwent PR with either PRF or CTG placed with SI in the maxillary anterior region were included in the study. Baseline (BL) and follow-up (T1( first month), T3 (third month), T6 (sixth month)) clinical data including periodontal evaluations (gingival index (GI), plaque index (PI), papillary bleeding index, pocket depth (PD), keratinized tissue width (KTW), gingival recession), papilla-associated recordings (alveolar crest-interdental contact point (AC-IC), alveolar crest-papilla tip (AC-PT), papilla tip-interdental contact point (PT-IC), papilla height loss (PHL), interdental tissue stroke (ITS) and papilla presence index (PPI)) and patient satisfaction were analyzed.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All selected patients had consent for using their data. * The data of the patients who underwent PR surgery by one of the authors (S.O.B.) using SI with either PRF or CTG in the maxillary anterior teeth having contact points, * at least 2 mm keratinized tissue width (KTW) with probing depth (PD)≤ 3 mm adjacent to the open embrasure were included. * It was ensured that all baseline (BL) and follow-up data were available and all patients received a comprehensive phase I periodontal treatment prior to the PR procedure. Exclusion Criteria: * the patients with systemic problems, * having medications known to influence the periodontium * Using tobacco/alcohol * The relevant regions did not have endodontic problems/needs, caries and history of periodontal surgery.

What they're measuring

Alveolar crest-Interdental contact point (AC-IC mm)

Timeframe: baseline

Alveolar crest-Interdental contact point (AC-IC mm)

Timeframe: T1:1st month

Alveolar crest-Interdental contact point (AC-IC mm)

Timeframe: T3:3rd month

Alveolar crest-Interdental contact point (AC-IC mm)

Timeframe: T6: 6th month

Alveolar crest-Papilla tip (AC-PT mm)

Timeframe: baseline

Alveolar crest-Papilla tip (AC-PT mm)

Timeframe: T1:1st month

Alveolar crest-Papilla tip (AC-PT mm)

Timeframe: T3:3rd month

Alveolar crest-Papilla tip (AC-PT mm)

Timeframe: T6: 6th month

Trial details

NCT IDNCT05207696

SponsorHacettepe University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-11-01

View on ClinicalTrials.gov More To Evaluate the Efficacy of Platelet-rich Fibrin in Papilla Reconstruction trials

Plain-language summary

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Alveolar crest-Interdental contact point (AC-IC mm)

Timeframe: baseline

Alveolar crest-Interdental contact point (AC-IC mm)

Timeframe: T1:1st month

Alveolar crest-Interdental contact point (AC-IC mm)

Timeframe: T3:3rd month

Alveolar crest-Interdental contact point (AC-IC mm)

Timeframe: T6: 6th month

Alveolar crest-Papilla tip (AC-PT mm)

Timeframe: baseline

Alveolar crest-Papilla tip (AC-PT mm)

Timeframe: T1:1st month

Alveolar crest-Papilla tip (AC-PT mm)

Timeframe: T3:3rd month

Alveolar crest-Papilla tip (AC-PT mm)

Timeframe: T6: 6th month